Elutia Inc Sustainability Reports
Elutia Inc. develops and commercializes proprietary biologic products and drug-eluting biomaterials. The company focus on products for cellular therapies, orthopedic procedures, and regenerative medicine.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00BRBB847
2 reports from 2023 to 2024
Company Profile
Elutia Inc. develops and commercializes proprietary biologic products and drug-eluting biomaterials. The company focus on products for cellular therapies, orthopedic procedures, and regenerative medicine.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
